In a filing, Decoy Therapeutics Inc revealed its Director HANISH ARNOLD C unloaded Company’s shares for reported $10.0 on Dec 30 ’25. In the deal valued at $0.64 per share,15 shares were sold. As a result of this transaction, HANISH ARNOLD C now holds 5,000 shares worth roughly $6250.0.
Then, HANISH ARNOLD C sold 12 shares, generating $8 in total proceeds. Upon selling the shares at $0.64, the Director now owns 0 shares.
Before that, HANISH ARNOLD C bought 5,000 shares. Decoy Therapeutics Inc shares valued at $3,740 were divested by the Director at a price of $0.75 per share. As a result of the transaction, HANISH ARNOLD C now holds 5,015 shares, worth roughly $6268.75.
Ladenburg Thalmann initiated its Decoy Therapeutics Inc [DCOY] rating to a Buy in a research note published on April 27, 2020; the price target was $3.80.
Price Performance Review of DCOY
On Tuesday, Decoy Therapeutics Inc [NASDAQ:DCOY] saw its stock jump 53.37% to $1.25. Over the last five days, the stock has gained 92.31%. Decoy Therapeutics Inc shares have fallen nearly -94.68% since the year began. Nevertheless, the stocks have risen 92.66% over the past one year.
How much short interest is there in Decoy Therapeutics Inc?
A steep rise in short interest was recorded in Decoy Therapeutics Inc stocks on 2025-12-15, dropping by -0.28 million shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.47 million shares. There was a decline of -153.4%, which implies that there is a negative sentiment for the stock.
